Latest headline: $PFE, Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2

https://t.co/12mbtelq4e

#stockstowatch #premarket #DayTrading #NYSE #Pfizer